Adjuvant Therapy With an Alpha-lactalbumin Vaccine in Triple-Negative Breast Cancer

Clinical trial NCT04674306 · COMPLETED

Trial details

NCT number: NCT04674306
Sponsor: George T. Budd
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Pathologic Stage IIA-IIIC Triple-Negative Breast Cancer TNBC - Triple-Negative Breast Cancer Residual Disease

Start date: 2021-10-01
Primary completion: 2025-12-15
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.